TRPV4 and neuropathy: Given the extensive level of TRPV4 channel expression in sensory and immune cells and its broad participation in physiological processes and diseases [59,61,117], the potential relevance of targeting TRPV4 inhibitors as therapeutical options to treat painful neuropathy associated with antineoplastic drugs is suggested [19,87].